Organovo Holdings Company
Organovo develops a range of tissue and disease models for medical research and therapeutic applications.
Founded Date:
2007
Total Funding:
$117.4M
Employee Number:
51-100
Funding Status:
IPO
Technology:
Others
Last Funding Type:
Series E
Investors Number:
2
Industry:
PharmTech
Headquarters:
San Diego, California, United States
Estimated Revenue:
$1M to $10M